Work

Newer Targeted Agents in NSCLC: TAK-788, an EGFR and HER2 Inhibitor

Year: 2018

Type: article

Author: Robert C. Doebele

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2930885148

FWCI:

Cites:

Cited by:

Related to: 10